SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 11.59 |
| Enterprise Value ($M) | -28.09 |
| Book Value ($M) | 51.21 |
| Book Value / Share | 5.30 |
| Price / Book | 0.23 |
| NCAV ($M) | 49.33 |
| NCAV / Share | 5.11 |
| Price / NCAV | 0.23 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.84 |
| Return on Assets (ROA) | -0.27 |
| Return on Equity (ROE) | -0.48 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.27 |
| Current Ratio | 3.27 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 80.67 |
| Assets | 82.55 |
| Liabilities | 31.33 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 43.95 |
| Operating Income | -44.79 |
| Net Income | -43.50 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -76.98 |
| Cash from Investing | -0.19 |
| Cash from Financing | -1.28 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | EcoR1 Capital, LLC | 4.00 | -31.98 | |
| 13D/A | Sofinnova Capital Vi Fcpr | 2.60 | -90.00 | |
| 13G/A | Invus Global Management, LLC | 5.90 | ||
| 13G | Artal International S.C.A. | 5.90 | 463.83 | |
| 13D | Baker Bros. Advisors Lp | 9.99 | 20.42 | |
| 13G/A | Redmile Group, LLC | 1.10 | -80.52 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 26,001 | 101,063 | 25.73 | |
| 20,119 | 71,344 | 28.20 | |
| 6,719 | 19,242 | 34.92 | |
| 38,189 | 119,874 | 31.86 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| GTBP – GT Biopharma, Inc. | GYRE – Gyre Therapeutics, Inc. |
| HEPA – Hepion Pharmaceuticals, Inc. | HOTH – Hoth Therapeutics, Inc. |
| HRTX – Heron Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io